β-Amyloid (42-1), human

This human β-Amyloid (42-1) peptide is the inactive reverse-sequence control for the neurotoxic Aβ (1-42) . It is widely utilized in both in vitro and in vivo Alzheimer's disease research to establish experimental baselines and study disease mechanisms.